CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$30.71
+0.49%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$31.70
From 52W high−4.83%
Volume2.09M
Market cap$8.68B
P/E (TTM)82.6x
P/S (TTM)8.8x
Div yield—
Key dataOct 19, 2026
Open
$31.70
From 52W high
−4.83%
Volume
2.09M
Market cap
$8.68B
ValuationView details →
P/E (Fwd)
99.7x
EV/EBITDA
48.3x
P/E (TTM)
82.6x
RSI (14)
58.2
MomentumView details →
1D Return
+0.49%
YTD Return
+14.60%
Similar companies
Latest newsMore news →
Caris Life Sciences, Inc. announced the launch of a national commercial promoting its Caris Detect multi-cancer early detection test, featuring Jordan Spieth.18h agoCaris Life Sciences, Inc. announced that it will report its third-quarter 2026 financial results on November 4, 2026, and host a live webcast at 3:30 p.m.5d ago